It also helps people understand why single-peptide therapy can help yet still feel incomplete
DOI:10.1016/S8756-3282(98)00180-X M.Staresinic,B.Sebecic,L.Patrlj,S.Jadrijevic,S.Suknaic,D.Perovic,G.Aralica,N.Zarkovic,S.Borovic,M.Srdjak,K.Hajdarevic,M.Kopljar,L.Batelja,A.Boban-Blagaic,I.Turcic, Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
Common research protocols frequently investigate: 2.3mg once daily (10 units) 5 days weekly with 2 rest days More intensive protocols may investigate 2.3mg twice daily in advanced research settings Because Glow Blend contains GHK-Cu, many research protocols commonly include: Daily zinc supplementation Daily vitamin C supplementation to support collagen-related, antioxidant-support, skin-integrity, and regenerative research pathways while helping maintain copper and zinc balance in some research settings
Frequency of treatment is determined based on your goals and provider recommendation
Human clinical trial data remains sparse, and the compound shares much of BPC-157's regulatory history: popular before 2023, restricted under Biden-era FDA action, and now under consideration for reinstatement